Shares of Aehr Test Systems surged 9.4% to $114.72 on June 17 as investors continued to pile into a stock that has become a pure-play bet on AI chip quality control — even as the price has blown past every Wall Street target on the board.
A Single $41 Million Order Rewrote the Whole Story. In April, Aehr landed the largest contract in its history — a $41 million follow-on production order from its lead hyperscale customer for systems that stress-test custom AI processors before they ship. That process, called "burn-in," catches defective chips early, and it has become essential as AI data centers demand near-perfect reliability. The single order pushed second-half fiscal 2026 bookings past $92 million, already exceeding management's recently raised guidance range of $60–$80 million. For a company with a market value of roughly $3.6 billion and annual revenue of just $45.3 million , the gap between what's booked and what's been billed is the entire bull case.
Revenue Is Still Falling — Bookings Are a Promise, Not a Paycheck. The most recent quarter showed a $0.11 loss per share, revenue down 27% year-over-year to $9.88 million, and net losses widening 214%.
Deliveries on the record order don't start until fiscal 2027, beginning late June 2026. Investors are pricing in a revenue surge that hasn't arrived yet, banking that backlog converts smoothly into shipments.
Silicon Photonics Adds a Second Growth Lane. Aehr's stock jumped 11% on a separate follow-on order for wafer-level burn-in systems from a major silicon photonics customer — a global leader in networking products developing advanced optical transceivers for high-speed data center links. This matters because it reduces dependence on one hyperscaler. Aehr's wafer-level systems are now deployed at more than 25 customers.
The Stock Has Left Analysts Behind — and Insiders Are Selling. The average analyst rating is "Buy," but the consensus 12-month price target sits at just $63.67 — roughly 43% below today's price.
Insider sales totaling $28 million contrast with 69.69% institutional ownership , a tension that suggests executives are locking in gains while funds keep buying the AI narrative. Recent earnings showed falling revenue and negative margins, yet bookings of $37.2 million and backlog near $38.7 million signal demand is arriving ahead of reported results. The question is whether fiscal 2027 delivery ramps can justify a valuation that already assumes blockbuster growth.